EP0980261A4 - Methods for preventing and treating the insult-induced metabolic imbalance in humans and other animals - Google Patents

Methods for preventing and treating the insult-induced metabolic imbalance in humans and other animals

Info

Publication number
EP0980261A4
EP0980261A4 EP98920967A EP98920967A EP0980261A4 EP 0980261 A4 EP0980261 A4 EP 0980261A4 EP 98920967 A EP98920967 A EP 98920967A EP 98920967 A EP98920967 A EP 98920967A EP 0980261 A4 EP0980261 A4 EP 0980261A4
Authority
EP
European Patent Office
Prior art keywords
insult
humans
animals
treating
preventing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98920967A
Other languages
German (de)
French (fr)
Other versions
EP0980261A1 (en
Inventor
Marian L Kruzel
Gilbert A Castro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of EP0980261A1 publication Critical patent/EP0980261A1/en
Publication of EP0980261A4 publication Critical patent/EP0980261A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP98920967A 1997-05-03 1998-04-30 Methods for preventing and treating the insult-induced metabolic imbalance in humans and other animals Withdrawn EP0980261A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4552197P 1997-05-03 1997-05-03
US45521P 1997-05-03
PCT/US1998/009053 WO1998050076A1 (en) 1997-05-03 1998-04-30 Methods for preventing and treating the insult-induced metabolic imbalance in humans and other animals

Publications (2)

Publication Number Publication Date
EP0980261A1 EP0980261A1 (en) 2000-02-23
EP0980261A4 true EP0980261A4 (en) 2003-04-23

Family

ID=21938377

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98920967A Withdrawn EP0980261A4 (en) 1997-05-03 1998-04-30 Methods for preventing and treating the insult-induced metabolic imbalance in humans and other animals

Country Status (5)

Country Link
EP (1) EP0980261A4 (en)
AU (1) AU7368198A (en)
CA (1) CA2288982A1 (en)
PL (1) PL336626A1 (en)
WO (1) WO1998050076A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030203839A1 (en) * 1999-10-29 2003-10-30 Kruzel Marian L. Immune enhancing composition containing lactoferrin
JP2006515879A (en) * 2003-01-07 2006-06-08 エヌ．ブイ．・ヌートリシア Method for improving nutrient utilization by mammals and compositions for use therein
ITMI20052351A1 (en) † 2005-12-09 2007-06-10 Microbo Srl NEW PHARMACEUTICAL USE OF TRANSFERRIN AND DERIVED PHARMACEUTICAL COMPOSITIONS

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4008033A1 (en) * 1990-03-14 1991-09-19 Nitsche Dietrich USE OF LACTOFERRINE TO CONTROL THE TOXIC EFFECT OF ENDOTOXIN
EP0559425A1 (en) * 1992-03-02 1993-09-08 Immuno Japan Inc. Formulated medicine for treatment and/or prevention of opportunistic infectious diseases complicated by infection with lentivirus
EP0730868A1 (en) * 1995-02-17 1996-09-11 Tamotsu Satoh Formulated medicines for treatment of oral inflammation, and processed foods to treat and prevent stomatitis
EP0753308A2 (en) * 1995-07-12 1997-01-15 Gambit International Limited Use of lactoferrin for therapy of acute or recurrent infectious diseases by streptococcus pyogenes or other intracellular gram positive pathogen bacteria
WO1998006425A1 (en) * 1996-08-12 1998-02-19 A+ Science Invest Ab Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin
WO1998033509A2 (en) * 1997-02-03 1998-08-06 Pharming Intellectual Property Bv Useful properties of human lactoferrin and variants thereof
WO1998044940A1 (en) * 1997-04-10 1998-10-15 Agennix, Inc. Use of lactoferin in the treatment of allergen induced disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977137B1 (en) * 1987-06-03 1994-06-28 Baylor College Medicine Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
US5792751A (en) * 1992-04-13 1998-08-11 Baylor College Of Medicine Tranformation of cells associated with fluid spaces

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4008033A1 (en) * 1990-03-14 1991-09-19 Nitsche Dietrich USE OF LACTOFERRINE TO CONTROL THE TOXIC EFFECT OF ENDOTOXIN
EP0559425A1 (en) * 1992-03-02 1993-09-08 Immuno Japan Inc. Formulated medicine for treatment and/or prevention of opportunistic infectious diseases complicated by infection with lentivirus
EP0730868A1 (en) * 1995-02-17 1996-09-11 Tamotsu Satoh Formulated medicines for treatment of oral inflammation, and processed foods to treat and prevent stomatitis
EP0753308A2 (en) * 1995-07-12 1997-01-15 Gambit International Limited Use of lactoferrin for therapy of acute or recurrent infectious diseases by streptococcus pyogenes or other intracellular gram positive pathogen bacteria
WO1998006425A1 (en) * 1996-08-12 1998-02-19 A+ Science Invest Ab Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin
WO1998033509A2 (en) * 1997-02-03 1998-08-06 Pharming Intellectual Property Bv Useful properties of human lactoferrin and variants thereof
WO1998044940A1 (en) * 1997-04-10 1998-10-15 Agennix, Inc. Use of lactoferin in the treatment of allergen induced disorders

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
FRITSCH G ET AL: "PLASMODIUM FALCIPARUM: INHIBITION IN VITRO WITH LACTOFERRIN, DESFERRIFERRITHIOCIN, AND DESFERRICROCIN", EXPERIMENTAL PARASITOLOGY, NEW YORK, NY, US, vol. 63, no. 1, February 1987 (1987-02-01), pages 1 - 9, XP000901232, ISSN: 0014-4894 *
GILLIN F D ET AL: "KILLING OF GIARDIA LAMBLIA TROPHOZOITES BY NORMAL HUMAN MILK", JOURNAL OF CELLULAR BIOCHEMISTRY, LISS, NEW YORK, NY, US, vol. 23, 1983, pages 47 - 56, XP000901160, ISSN: 0730-2312 *
MACHNICKI MICHAL ET AL: "Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo.", INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, vol. 74, no. 5, 1993, pages 433 - 439, XP009006113, ISSN: 0959-9673 *
See also references of WO9850076A1 *
ZAGULSKI T ET AL: "LACTOFERRIN CAN PROTECT MICE AGAINST A LETHAL DOSE OF ESCHERICHIA-COLI IN EXPERIMENTAL INFECTION IN-VITRO", BRITISH JOURNAL OF EXPERIMENTAL PATHOLOGY, vol. 70, no. 6, 1989, pages 697 - 704, XP009006349, ISSN: 0007-1021 *

Also Published As

Publication number Publication date
CA2288982A1 (en) 1998-11-12
AU7368198A (en) 1998-11-27
WO1998050076A1 (en) 1998-11-12
EP0980261A1 (en) 2000-02-23
PL336626A1 (en) 2000-07-03

Similar Documents

Publication Publication Date Title
AU732769C (en) Security cage for game machine and game machine using the same
HK1003170A1 (en) Game machine and game machine system using the same
HUP0004170A3 (en) Methods and materials for treating and preventing inflammation ofmucosal tissue
AP9801175A0 (en) Quinoline and quinoline compounds useful in therapy
ZA973503B (en) Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents.
PL336349A1 (en) Compositions for and methods for treating and diagnosing the mastocarcinoma
IL144561A0 (en) Liposome compositions and methods for treating pests utilizing the same
PL330762A1 (en) Pesticide preparation in the form of pellets
GB9518209D0 (en) Improvements in quilts and the like
ZA981781B (en) The use of levobupivacaine in treating migraine
GB9809448D0 (en) Treatment device and method
EP0980261A4 (en) Methods for preventing and treating the insult-induced metabolic imbalance in humans and other animals
GB9709029D0 (en) Apparatus for partitioning animals in farm buildings and the like
GB2307417B (en) Games,puzzles and the like
HU9603575D0 (en) Amino-acid-derivatives and their use as pesticide
EP1015001A4 (en) Method for treating impetigo and the like
PL337665A1 (en) (s) 2-methylamine-2-phenyl-n-butyl-3,4,5-trimethoxybezoate and application thereof in treating long-lasting pains
HUP0102995A3 (en) Agents and method for the protective treatment of wood
GB9609944D0 (en) An improvement in the treatment of wastes
HU9602567D0 (en) N-aryl and n-alkylsulphonylaminals as pesticides
ZA974326B (en) Microparticles and their use in wound therapy.
GB9818018D0 (en) Microparticles and their use in therapy
GB9403180D0 (en) Transportable target and ball
GB9704864D0 (en) Slymgym and super slym
AU1374599A (en) Materials and methods for preventing cellular injury in humans and animals

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19991130

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20030310

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61P 33/00 B

Ipc: 7A 61P 31/00 B

Ipc: 7A 61P 29/00 B

Ipc: 7A 61K 38/40 A

17Q First examination report despatched

Effective date: 20030610

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20071031